GSK3β guides chromosomal repair pathway selection to support BRCA1-independent PARP inhibitor sensitivity
Journal of Clinical Investigation · 2025
DOI: 10.1172/jci197910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Justin W Leung und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Mays Cancer Center at University of Texas Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of M…. Hauptthemen laut MEDLINE: BRCA1 Protein, Poly(ADP-ribose) Polymerase Inhibitors, DNA End-Joining Repair, Glycogen Synthase Kinase 3. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Mays Cancer Center at University of Texas Health San Antonio MD Anderson, Joe R. and Teresa Lozano Long School of Medicine, San Antonio, Texas, USA.
- Barshop Institute for Longevity and Aging Studies, University of Texas Health San Antonio, San Antonio, Texas, USA.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Leung, J. W., & Gius, D. (2025). GSK3β guides chromosomal repair pathway selection to support BRCA1-independent PARP inhibitor sensitivity. Journal of Clinical Investigation. https://doi.org/10.1172/jci197910
Vancouver
Leung JW, Gius D. GSK3β guides chromosomal repair pathway selection to support BRCA1-independent PARP inhibitor sensitivity. Journal of Clinical Investigation. 2025. doi:10.1172/jci197910
BibTeX
@article{Leung2025,
author = {Leung, Justin W and Gius, David},
title = {GSK3β guides chromosomal repair pathway selection to support BRCA1-independent PARP inhibitor sensitivity},
journal = {Journal of Clinical Investigation},
year = {2025},
doi = {10.1172/jci197910}
}
EUVIMED